Scientists continue to investigate how cannabinoids may interact with the immune system, especially in conditions involving chronic inflammation and autoimmune responses. In the review “Cannabinoids in autoimmune diseases: mechanistic insights and translational challenges,” researchers examined how cannabinoids may influence immune pathways connected to autoimmune disorders such as multiple sclerosis, rheumatoid arthritis, lupus, and type 1 […]
Tag: anti‑inflammatory
CBG Demonstrates Anti-Inflammatory, Neuroprotective, and Antibacterial Activity (pub. Nov 2022)
Cannabigerol (CBG) is often called the “mother cannabinoid” because it serves as a precursor from which other major cannabinoids, including CBD and THC, are formed during the cannabis plant’s growth. In this 2022 scientific review, researchers examined the pharmacological properties of CBG and its synthetic derivatives, highlighting growing interest in the compound for its potential […]
Cannabigerol (CBG) and Drug-Resistant Epilepsy: A Review of Neuroprotective and Anti-Inflammatory Mechanisms (pub. March 2026)
Drug-resistant epilepsy affects a significant portion of people with epilepsy and is often linked to underlying processes such as chronic neuroinflammation, oxidative stress, and progressive neuronal damage. This review explores the potential role of cannabigerol (CBG), a non-intoxicating cannabinoid, by examining how it interacts with biological systems involved in brain health. Rather than focusing on […]